Sichuan Luyan Pharmaceutical Co., Ltd. announced that it will receive CNY 200,000,000 in an equity round of funding from returning investor Luyan Pharma Co.,Ltd. on October 27, 2021. on closing, the investor retains its 100% stake in the company. Post-closing, the registered capital of the company will increase from CNY 22,000,000 to CNY 222,000,000.

The transaction has been approved by board of directors of Luyan Pharma Co.,Ltd in its seventh meeting of the fifth board of directors and does not need the shareholders' approval.